"Mom of 2 dies of the flu after deciding medication was too expensive."

AOL News, 2/20/18

The message is clear. Had Heather Holland been able to afford the $116 copay for a box of Tamiflu, the flu that killed her would now be a thing of the past and she would probably be back to work. There is at least some implicit blame of the pharmaceutical industry as well. Just an ordinary story.

Except it's probably all wrong. There are a number of clues in the story that explain to us why this is so.

The original story appeared in the Weatherford Democrat News on Monday, February 5th. According to her husband Frank, Ms. Holland, who died on February 4th, came down with the flu around Sunday, January 28th. Ms. Holland saw her doctor, who prescribed Tamiflu. But she decided that the $116 co-pay was too expensive and did not fill the prescription.

Later in the week (the time interval is not clear) Frank Holland filled the prescription, but by Friday, February 3rd his wife was gravely ill; the Tamiflu made no difference. By Saturday Ms. Holland was hospitalized and undergoing dialysis. She died the next day.

What really happened in this awful story can be gleaned from clues, which no one in the press seemed to notice. Once we understand what these clues mean, a very different story emerges.

Timing: If Ms. Holland did not see her doctor immediately after she felt ill, chances are that the absolute earliest that she could have begun Tamiflu treatment would have been a day or two after she came down with the flu. Tamiflu is a highly imperfect drug (1). Its efficacy is modest at best, and to derive any benefit from it, the victim of the flu must take the drug within 24 (possibly 48) hours of the beginning of symptoms. After that, it won't work. And in this case, it didn't matter. Keep reading.

Sudden deterioration: This years' flu is killing people in at least two different ways: 1) from secondary infections, such as pneumonia, and 2) directly and rapidly because it provokes a violent overreaction of the immune system, which creates a very dangerous condition called a cytokine storm. (2) Cytokine storm is very similar to septic shock, another serious malfunction of the immune system that kills about 50% of those who develop it.

Treatment by the hospital: As is the case with sepsis, a cytokine storm commonly causes rapid irreversible kidney damage. This explains why Ms. Holland received dialysis and died shortly thereafter. There is no other reason that she would be given dialysis (3).

Cause of death: The fact that Ms. Holland died from kidney failure, not pneumonia, makes it almost a given that she was the victim of cytokine storm. Tamiflu will not protect you from a cytokine storm.

So, the real story is really quite different from what is being told in the press. Ms. Holland did not die because she couldn't afford flu medication. The medication would have made no difference. She died because she was unfortunate enough to have an immune system that went haywire when presented with a particular flu strain. The only thing that might have made a difference would have been a flu shot (assuming she hadn't gotten one already).

I cannot stress enough how important it is to get this vaccine. It is extremely safe and even though the strains in the vaccine don't do a very good job of matching those that are circulating, it still can offer partial immunity to whatever strain you catch (4). This one's a no-brainer.

Dr. Josh Bloom, the Director of Chemical and Pharmaceutical Science, is a recognized expert on the opioid crisis and was the first journalist to write a nationally published opinion piece about the unintended consequences of a governmental crackdown on prescriptions opioids (New York Post, 2013). Since that time he has published more than a dozen op-eds in regional and national newspapers on different aspects of the crisis. In that same year, he testified at an FDA hearing and was the only speaker to note that fentanyl was the real killer, something that would be proven years later.

He was also the first writer (2016) to study, dissect and ultimately debunk the manipulated statistics used by the CDC to justify its recommendations for opioid prescribing, which have resulted in draconian requirements for prescribing pain medications as well as government-mandated, involuntary tapering of patients receiving opioid treatment, both of which have caused great harm and needless suffering to chronic pain patients. His 2016 article, "Six Charts Designed to Confuse You," is the seminal work on CDC deception and has been adopted by patient advocacy groups and individuals and has been sent to governors and state legislatures.

Dr. Bloom earned his Ph.D. in organic chemistry from the University of Virginia, followed by postdoctoral training at the University of Pennsylvania. He worked for more than two decades in drug discovery research at Lederle Laboratories, which was acquired by Wyeth in 1994, which itself was acquired by Pfizer in 2009. During this time he conducted research in a number of therapeutic areas, including diabetes and obesity, antibiotics, HIV/AIDS, hepatitis C, and oncology. His group discovered the novel antibiotic Tygacil®, which was approved by the FDA for use against resistant bacterial infections in 2005. He is the author of 25 patents, and 35 academic papers, including a chapter on new therapies for hepatitis C in Burger’s Medicinal Chemistry, Drug Discovery and Development, 7th Edition (Wiley, 2010), and has given numerous invited lectures about how the pharmaceutical industry really works.

Dr. Bloom joined the American Council on Science and Health in 2010 as ACSH’s Director of Chemical and Pharmaceutical Sciences, and has since published 50 op-eds in numerous periodicals, including The Wall Street Journal, Forbes, New Scientist, The New York Post, National Review Online, The Boston Herald, and The Chicago Tribune, and given numerous radio and television interview on topics related to drugs and chemicals. In 2014, Dr. Bloom was invited to become a featured writer for the site Science 2.0, where he wrote more 75 pieces on a broad range of topics.

We are funded mostly by readers like you. Please consider donating!

"Big Fears Little Risks" is a documentary, but unlike most of what you see on places like Netflix, it is pro-science, and not scaremongering trace chemicals, food, or the modern world. We instead are going to take back the discourse from trial lawyers and the trade groups they use to profit from fear.

The American Council on Science and Health is a research and education organization operating under Section 501(c)(3) of the Internal Revenue Code. Contributions are fully tax-deductible. ACSH does not accept government grants or contracts, nor do we have an endowment. We raise our funds each year primarily from individuals and foundations.